Detalhe da pesquisa
1.
AAV9-NGLY1 gene replacement therapy improves phenotypic and biomarker endpoints in a rat model of NGLY1 Deficiency.
Mol Ther Methods Clin Dev
; 27: 259-271, 2022 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36320418
2.
Analytical Validation of a Highly Quantitative, Sensitive, Accurate, and Reproducible Assay (HERmark) for the Measurement of HER2 Total Protein and HER2 Homodimers in FFPE Breast Cancer Tumor Specimens.
Patholog Res Int
; 2010: 814176, 2010 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-21151530